Nigeria’s $5 billion health cooperation agreement with the United States has come under fresh scrutiny following concerns over the sharing of medical data, biological samples and the long-term obligations attached to the deal.
The controversy intensified after Ghanaian President John Dramani Mahama disclosed that his country had rejected a similar proposed agreement with the US over concerns about data protection and other conditions. <Cite refs={[“turn303628search8″,”turn303628search13”]}/>
The five-year Memorandum of Understanding (MoU), signed by Nigeria and the US on December 19, 2025, is designed to strengthen healthcare delivery, disease surveillance, laboratory systems and responses to infectious diseases.
Under the arrangement, the US intends to provide nearly $2.1 billion in health assistance, while Nigeria plans to commit approximately $3 billion in additional domestic health expenditure over the same period. <Cite refs={[“turn303628search11″,”turn303628search15”]}/>
Concerns over medical data and biological samples
One of the major issues surrounding the agreement is a provision allowing the US government to continue using previously shared biological specimens and related data even if Nigeria terminates the specimen-sharing arrangement.
Medical experts have raised questions about the implications of this clause, arguing that the agreement should clearly define how long the information and samples can be retained, how they may be used and what protections apply after termination.
Professor Innocent Ujah, a former president of the Nigerian Medical Association, acknowledged that sharing health information for research and public health purposes is common practice. However, he questioned whether continued use of specimens and related data after termination adequately protects Nigeria’s interests.
Other experts have also warned that interconnected electronic health records could create privacy and security risks if safeguards against unauthorised access, re-identification and the use of information for unrelated purposes are insufficient. <Cite refs={[“turn303628search8″,”turn303628search11”]}/>
Questions over Nigeria’s financial commitments
The agreement has also generated questions about Nigeria’s capacity to meet its proposed $3 billion domestic expenditure commitment.
Former Vice-President Atiku Abubakar has called on the Federal Government to publish the full agreement, arguing that Nigerians deserve to understand its financial obligations and the conditions governing the partnership.
Concerns have also been raised about whether the government can sustain the planned spending commitments amid questions about the release of funds for existing health projects. <Cite refs={[“turn303628search8″,”turn303628search13”]}/>
Government highlights potential health benefits
The Federal Government has presented the agreement as an opportunity to strengthen Nigeria’s health system, improve disease detection and expand access to essential healthcare services.
The partnership is expected to support programmes addressing HIV/AIDS, tuberculosis, malaria and maternal and child health, while improving laboratory capacity and the availability of health commodities.
The US has also indicated that the arrangement will support frontline healthcare workers and strengthen digital health information systems.
However, the debate has highlighted the need for transparency, effective data protection and clear accountability mechanisms to ensure that the benefits of international health assistance are matched by adequate safeguards for Nigerian citizens.
As scrutiny continues, attention is expected to focus on the full terms of the agreement, the management of medical data and biological samples, and the government’s ability to fulfil its financial commitments.
#Nigeria #USHealthDeal #HealthSector #MedicalData #DataPrivacy #HealthcareFunding #PublicHealth #TrendsReporters
